Skip to Content

Notice

Foreign-Trade Zone 22-Chicago, Illinois, Authorization of Production Activity, Abbott Laboratories, Inc., AbbVie, Inc. (Pharmaceutical Production), North Chicago, Illinois, Area

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

On December 14, 2012, Abbott Laboratories, Inc., and AbbVie, Inc., submitted a notification for expanded production authority within Subzones 22F and 22S, respectively, at sites located in the North Chicago and Lake County, Illinois, area.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (77 FR 75610, 12-21-2012). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board's regulations, including Section 400.14.

Start Signature

Dated: April 12, 2013.

Elizabeth Whiteman,

Acting Executive Secretary.

End Signature End Preamble

[FR Doc. 2013-09163 Filed 4-17-13; 8:45 am]

BILLING CODE P